Treatment-related leukoencephalopathy: A study of three cases and literature review

Medicine (United States)

Volumn 65, Issue 3, 1986, Pages 154-162

  Glass, J Peter ^a   Lee, Ya Yen ^a   Bruner, Janet ^a   Fields, William S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; DACTINOMYCIN; DOXORUBICIN; FOLINATE CALCIUM; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE DRUG REACTION; AUTOPSY; BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHEMOTHERAPY; DRUG THERAPY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; NERVOUS SYSTEM; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOTHERAPY; THERAPY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CASE REPORT; CYTARABINE; DIAGNOSIS, DIFFERENTIAL; HUMAN; LEUKEMIA, LYMPHOCYTIC; MALE; METHOTREXATE; OSTEOSARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0022453445     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198605000-00003     Document Type: Article

References (47)

1. Abelson HT. Methotrexate and central nervous system toxicity. Cancer Treat Rep 62: 1999-2001, 1978.
2. Addiego JE, Ridgway D, Bleyer WA. The acute management of intrathecal methotrexate overdose: Pharmacologic rationale and guidelines. J Pediatr 98: 825-828, 1981.
3. Allen JC, Rosen G. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma. Ann Neurol 3: 441-444, 1978.
4. Allen JC, Rosen G, Mehta BM, Horten B. Leukoencephalopathy following high-dose IV methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64: 1261-1273, 1980.
5. Bedikian A, Valdivieso M, Luna M, Bodey GP. Nonbacterial thrombotic endocarditis in cancer patients: Comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. Med Pediatr Oncol 4: 149-157, 1978.
6. Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 39: 95-98, 1982.
7. Bleyer WA. Current status of intrathecal chemotherapy in human meningeal neoplasms. Natl Cancer Inst Monogr 46: 171-178, 1977.
8. Bleyer WA. Neurological sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 65: 89-98, 1981.
9. Burger PC, Kamenar E, Schold SC, Fay JW, Phillips GL, Herzig GP. Encephalomyelopathy following high-dose BCNU therapy. Cancer 48: 1318-1327, 1981.
10. Catane R, Schwade JG, Yarr I, Lichter AS, Tepper JE, Dunnick NR, Brody L, Brereton HD, Cohen M, Glatstein E. Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiation Oncology Biol Phys 7: 105-109, 1981.
11. Collins RCf Al-Mondhiry H, Chernik NL, Posner JB. Neurologic manifestations of intravascular coagulation in patients with cancer: A clinico-pathologic analysis of 12 cases. Neurology 25: 795-806, 1975.
12. Djerasei I, Kim JS, Schulman K. High-dose methotrexate-citrovorin factor rescue in the management of brain tumors. Cancer Treat Rep 61: 691-694, 1977.
13. Dutch DS, Bigner DD, Bowers SW, Nichol CA. Dihydrofolate reductase in primary brain tumors, cell cultures of central nervous system origin and normal brain during fetal and neonatal growth. Can Res 39: 487-491, 1979.
14. Fenstermacher JD, Cowles AL. Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61: 519-526.1977.
15. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WKA, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields WS. Intracarotid infusion of cis-diam-minedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794-799, 1984.
16. Finkelstein W, Isselbacher KJ. Cimetidine. N Engl J Med 299: 992-996.1978.
17. French JD, West PM, Von Amerongen FK, Magoun HW. Effects of intracarotid administration of nitrogen mustard on normal brain and brain tumors. J. Neurosurg 9: 378-389, 1952.
18. Gangji D, Reaman GH, Cohen SR, Bleyer A, Poplack DG. Leukoen-cephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med 303: 19-21, 1980.
19. Greenhouse A, Neuberger KJ, Bowerman DL. Brain damage after intracarotid infusion of methotrexate. Arch Neurol (Chicago) 11: 618-625, 1964.
20. Griffin TW, Rasey JS, Bleyer WA. The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer 40: 1109-1111, 1977.
21. Gutin PH, Levi JA, Wiernik PH, Walker MD. Treatment of malignant meningeal disease with intrathecal thio-TEPA: A phase J study. Cancer Treat Rep 61: 885-887, 1977.
22. Hopewell JW, Wright EA. The nature of latent cerebral irradiation damage and its modification by hypertension. Br J Radiol 43: 161-167, 1970.
23. Hwang T-L, Yung WKA, Estey EH, Fields WS. Central nervous system (CNS) toxicity with high-dose Ara-C. Neurology 35: 1475-1479, 1985.
24. Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30: 1627-1631, 1972.
25. Kaplan RS, Wiernik PH., Neurotoxicity of antineoplastic drugs. Semin Oncol 9(1): 103-130, 1982.
26. Kay HEM, Knapaton PJ, O'Sullivan JP, Wells DG, Harris RF, Innes EM, Stuart J, Schwartz FCM, Thompson EN. Encephalopathy in acute leukemia associated with methotrexate therapy. Arch Dis Child 47: 344-354, 1972.
27. Lampert PW, Tom J, Rider WD. Disseminated demyelination of the brain following Coee (gamma) radiation. Arch Pathol (Chicago) 68: 322-330, 1959.
28. Lee Y-Y, Glass JP, van Eys J, Wallace S. Medulloblastome in infants and children: Computed tomographic follow up after treatment. Radiology 154: 677-682, 1985.
29. Madajewicz S, West GR, Park HC, Ghoorah J, Avellanosa AM, Takita H, Karakousis C, Vincent R, Caracandae J, Jennings E. Phase J study-intra-arterial BCNU therapy for metastatic brain tumors. Cancer 47: 653-657, 1981.
30. McMillan MA, Ambis D, Siegel JH. Cimetidine and mental confusion. N Engl J Med 298: 284-285, 1978.
31. Peylan-Ramu N, Poplack DG, Pizzo PA, Adomato BT, DiChiro G. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298: 815-818, 1978.
32. Plum F, Posner JB. The diagnosis of stupor and coma. Philadelphia: F. A. Davis, 1982.
33. Pochadly C. Prophylactic CNS therapy in childhood acute leukemia: Review of methods used. Am J Ped Hematol Oncol 1: 119-126, 1979.
34. Price RA, Jamieson PA. The central nervous system in childhood leukemia, J. Subacute leukoencephalopathy. Cancer 35: 306-318, 1975.
35. Rosen G, Ghavimi F, Vanucci R, Deck M, Tan C, Murphy ML. Pontine glioma: High-dose methotrexate and leucovorin rescue. JAMA 230: 1149-1152, 1974.
36. Rottenberg DA, Chemik NL, Deck MDF, Ellis F, Posner JB. Cerebral necrosis following radiotherapy of extracranial neoplasms. Ann Neurol 1: 339-357, 1977.
37. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Diseeminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma. Cancer 35: 291-305, 1975.
38. Shapiro WR, Chemik NL, Posner JB. Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol 28: 96-102, 1973.
39. Shapiro WR, High-dose methotrexate in malignant gliomas. Cancer Treat Rep 6: 753-756, 1977.
40. Walker DL. PML: An opportunistic viral infection of the central nervous system. In: Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology, vol. 34, chapter 16. New York: North Holland, p. 307-329, 1979.
41. Wang JJ, Pratt CB. Intrathecal arabinosyl cytosine in meningeal leukemia. Cancer 25: 531-534, 1970.
42. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49: 759-772, 1982.
43. Weiss HD, Walker MD, Wiemik PH. Neurotoxicity of commonly - used antineoplastic agents. N Engl J Med 291: 75, 127-133, 1974.
44. Wendling LR, Bleyer WA, Di Chiro G, McIlvanie SK. Transient, severe peri-ventricular hypodensity after leukemic prophylaxis with cranial irradiation and intrathecal methotrexate. J Comput Assist Tomogr 2: 502-505, 1978.
45. Young DF, Posner JB. Nervous system toxicity of chemotherapeutic agents. In: Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology, vol. 39, chapter 4. New York: North Holland, p. 91-129, 1980.
46. Zeman W. Disturbances of nucleic acid metabolism preceding delayed radionecrosis of nervous tissue. Proc Nat Acad Sci USA 50: 626-630, 1962.
47. Zeman W, Samorajski T. Effects of irradiation on the nervous system. In: Berdjis GG (ed): Pathology of Irradiation. Baltimore, The Williams and Wilkins Company, p. 213-277, 1971.